Kailera Therapeutics: Funding, Investors & Team (Sep 2026)
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases.
Kailera Therapeutics has raised $1.0B across 2 funding rounds on record, the most recent a Series B of $600M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kailera Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Kailera Therapeutics Funding Rounds
Kailera Therapeutics raised $400M in a Series A announced in Oct 2024.
1 years later, a Series B of $600M was announced in Oct 2025.
Kailera Therapeutics Founders and Leadership Team
Contact details for the Kailera Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Kailera Therapeutics Funding Compared to Other Biotechnology Startups
Kailera Therapeutics' latest round of $600M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kailera Therapeutics in Biotechnology and Waltham
Companies Similar to Kailera Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Kailera Therapeutics Funding FAQs
What does Kailera Therapeutics do?
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases.
How much funding has Kailera Therapeutics raised?
Kailera Therapeutics has raised $1.0B across 2 rounds on record. The most recent is a Series B of $600M announced in Oct 2025.
When did Kailera Therapeutics last raise funding?
Kailera Therapeutics' most recent funding round on record is a Series B of $600M, announced in Oct 2025.
Who founded Kailera Therapeutics?
FundedIQ lists Ron Renaud (Founder) at Kailera Therapeutics.
Where is Kailera Therapeutics headquartered?
Kailera Therapeutics is based in Waltham, Massachusetts, United States.
How many employees does Kailera Therapeutics have?
Kailera Therapeutics is in the 11-50 employee band.
How does Kailera Therapeutics' funding compare to other Biotechnology startups?
Kailera Therapeutics' latest round of $600M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Kailera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kailera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.